These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28822054)

  • 1. Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.
    Patel HD; Chambliss JM; Gupta MR
    Curr Allergy Asthma Rep; 2017 Aug; 17(9):63. PubMed ID: 28822054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
    Valenta R; Campana R; Focke-Tejkl M; Niederberger V
    J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant allergy vaccines based on allergen-derived B cell epitopes.
    Valenta R; Campana R; Niederberger V
    Immunol Lett; 2017 Sep; 189():19-26. PubMed ID: 28472641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
    Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
    Front Immunol; 2020; 11():1368. PubMed ID: 32733455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vaccines for allergen-specific immunotherapy.
    Akinfenwa O; Rodríguez-Domínguez A; Vrtala S; Valenta R; Campana R
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):86-99. PubMed ID: 33369572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases.
    Edlmayr J; Niespodziana K; Focke-Tejkl M; Linhart B; Valenta R
    Curr Top Microbiol Immunol; 2011; 352():121-40. PubMed ID: 21626347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Treatments for Allergy: Advances in Peptide Immunotherapy.
    Calzada D; Baos S; Cremades L; Cardaba B
    Curr Med Chem; 2018; 25(19):2215-2232. PubMed ID: 29205109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights of Novel Vaccination Strategies in Allergen Immunotherapy.
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):15-24. PubMed ID: 31761116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrophagus putrescentiae group 4 allergen allergenicity and epitope prediction.
    Teng FX; Huang HF; Ge DZ; Yu LL; Xu C; Cui YB
    Allergol Immunopathol (Madr); 2020; 48(6):619-625. PubMed ID: 32418775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-based vaccination: where do we stand?
    Francis JN; Larché M
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):537-43. PubMed ID: 16264335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in development of hypoallergenic latex immunotherapy.
    Rolland JM; Drew AC; O'Hehir RE
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):544-51. PubMed ID: 16264336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.
    Prickett SR; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2015 Jun; 45(6):1015-26. PubMed ID: 25900315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy: current and new therapeutic strategies.
    Rolland JM; Douglass J; O'Hehir RE
    Expert Opin Investig Drugs; 2000 Mar; 9(3):515-27. PubMed ID: 11060692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant allergens for immunotherapy: state of the art.
    Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for peptide-based immunotherapy for dog allergy.
    Virtanen T
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):461-5. PubMed ID: 17088652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL; Singh MB
    Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunotherapy vaccine development.
    Jutel M; Akdis CA
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):557-63. PubMed ID: 25304230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.